References
Granger CB, et al. Drugs 44: 293–325, 1992
Freeman MR, et al. Circulation 85: 150–157, 1992
ISIS-3 Collaborative Group. Lancet 339: 753–770, 1992
Purvis JA, et al. Coron Art Dis 3: 713–720, 1992
Kalbfleisch J, et al. Am J Cardiol 69: 1120–1127, 1992
Darius H, Meyer J. Cardiovas Rev Rep 12: 56–59, 1991
Diefenbach C, et al. Coron Art Dis 3: 925–931, 1992
Kasper W, et al. J Am Coll Cardiol 16: 733–738, 1990
Gulba D, et al. Circulation 83: 837–944, 1991
Belgian Saruplase Alteplase Trial Group. Coron Art Dis 2: 349–355, 1991
Ostermann H, et al. Eur Heart J 13: 1225–1232, 1992
Rights and permissions
About this article
Cite this article
Future Directions in Thrombolytic Therapy. Drugs Ther. Perspect 1, 11 (1993). https://doi.org/10.2165/00042310-199301050-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199301050-00004